Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Sherry Pierce
Superior Outcome With Hypomethylating Therapy in Patients With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome and Chromosome 5 and 7 Abnormalities
Cancer
Cancer Research
Oncology
‹
1
2
3
Related publications
Acute Myeloid Leukemia After Myelodysplastic Syndrome and Failure of Therapy With Hypomethylating Agents: An Emerging Entity With a Poor Prognosis
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Idarubicin, Cytarabine and Pravastatin as Induction Therapy for Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia, and Acute Myeloid Leukemia Associated With Complete or Partial Monosomy 7
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Sequential Allogeneic Stem Cell Transplantation in High Risk Acute Myeloid Leukemia and Myelodysplastic Syndrome
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
CD30 Expression in High-Risk Acute Myeloid Leukemia and Myelodysplastic Syndromes
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Secondary Philadelphia Chromosome Acquired During Therapy of Acute Leukemia and Myelodysplastic Syndrome
Modern Pathology
Forensic Medicine
Pathology
Autologous Stem Cell Transplantation for Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome
Bone Marrow Transplantation
Transplantation
Hematology
A Phase II Study of AZD2171 (Cediranib) in the Treatment of Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
Combination Therapies of Hypomethylating Agents for Elderly Patients With Acute Myeloid Leukemia
Acta Haematologica Polonica
Oncology
Hematology
